UCSF Medical Center ranks among the nation’s top 10 premier hospitals for the tenth consecutive year and is the best in Northern California, according to the new 2010-2011 America’s Best Hospitals survey conducted by U.S. News & World Report.
June 23, 2010
Marc Benioff explained his excitement about building a new children’s hospital at Mission Bay and encouraged others to get involved in the project on June 22, when he officially announced his gift of $100 million to UCSF.
June 11, 2010
It is well-known that vitamin D is essential for strong and healthy bones. However, in an article in the online “In Press” section of “Trends in Endocrinology and Metabolism,” a San Francisco VA Medical Center physician reviews recent scientific literature suggesting that the vitamin may also play a role in preventing cancer, fighting infection, and controlling or preventing auto-immune disease.
June 07, 2010
A single dose of radiation administered during surgery is as effective for patients with early forms of breast cancer as standard radiation therapy that can take as long as six weeks, according to new research findings.
June 03, 2010
UCSF Children’s Hospital ranks among the nation’s best children’s hospitals in eight specialties and is one of the top-ranked facilities in California, according to the new 2010-11 “America’s Best Children’s Hospitals” survey conducted by U.S. News & World Report.
May 25, 2010
The UCSF Helen Diller Family Comprehensive Cancer Center hosted an afternoon event on the Mission Bay campus on May 12 to showcase recent progress and current research directions in the fight against cancer.
May 21, 2010
The cancer vaccine sipuleucel-T -- now commercially branded as Provenge -- will soon be available at a select group of medical centers nationwide, including UCSF.
May 17, 2010
Targeted therapies tailored to the unique biology of brain tumors may offer renewed hope to children diagnosed with the number one cause of cancer death, according to faculty at UCSF Children’s Hospital.
April 28, 2010
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) – the most common form of non-invasive breast cancer – are at risk of developing more invasive tumors in later years.
March 03, 2010
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.